Dr. Lois J Ayash M.D.
Hematologist-Oncologist | Hematology & Oncology
4100 John R St Karmanos Cancer Inst Detroit MI, 48201About
Dr. Lois Ayash is a hematologist oncologist practicing in Detroit, MI. Dr. Ayash specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Univ Of Ma Med Sch- Worcester Ma 1981
University Of Massachusetts Medical School 1981
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation.
- Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.
- Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.
- Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer.
- Analysis of 4-hydroxycyclophosphamide in human blood.
- A preclinical model for sequential high-dose chemotherapy.
- High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
- Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation.
- High dose chemotherapy with autologous stem cell support for the treatment of metastatic breast cancer.
- Antitumor efficacy and pharmacokinetic analysis of 4-hydroperoxycyclophosphamide in comparison with cyclophosphamide +/- hepatic enzyme effectors.
- Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin.
- High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma.
Clinical Trials
Treatments
- Acute Myeloid Leukemia (aml)
- Lymphoma
- Immunodeficiency
- Multiple Myeloma
- Leukemia
- Dermal Aesthetics
- Extra Corporeal Shockwave Therapy
Dr. Lois J Ayash M.D.'s Practice location
Dr. Lois J Ayash M.D.'s reviews
Write ReviewPatient Experience with Dr. Ayash
Recommended Articles
- Survey Shows Lack of Blood Cancer Knowledge Among Americans
If anyone is asked to describe what cancer is, chances are they’ll be able to provide at least a rough definition of the disease. Generally speaking, cancer is the name for the rapid and uncontrollable development of cells in a certain part of the body. In addition to holding a general awareness...
- Treatment Update for Hodgkin Lymphoma
Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...
- Woman Who Battled Lymphoma Three Times Starts Support Group
Battling cancer is just that - a battle. To make it through once is an incredible feat, but one Virginia Beach woman survived the terrible condition three times. Now, she is starting a support group so other women can have the incredible outcome she had as well.Lynne's storyUnfortunately, most...
- Life Lessons After Multiple Misdiagnoses of Lymphoma
28-year-old Jessica DeCristofaro had been coughing persistently and she was told by her doctor that it was a result of allergies. She even took medication for her supposed allergies over the course of two years. When the medication failed to improve her persistent cough, another doctor diagnosed her...
- Treatment Options of Multiple Myeloma
A team led by a consultant haematology specialist takes care of you if you are a multiple myeloma patient. The team discusses your situation and suggests the best treatment for you, but you will finally decide.It may be paramount to compile a list of questions which you will ask the specialist...
- Morphos Declared a "Breakthrough Therapy" for Lymphoma
MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
Nearby Providers
- Dr. Zyad Kafri MD4646 John R St Detroit MI 48201
- Mr. Zaid Al-kadhimi MD4100 John R St Detroit MI 48201
- Dr. Voravit Ratanatharathorn MD FACP4100 John R St Detroit MI 48201
- Dr. Andrew Aaron Muskovitz M.D.4100 John R St Detroit MI 48201
- Dr. Jay Yang M.D.4100 John R St Detroit MI 48201
- Dr. Joseph P Uberti MD PHD4100 JOHN R DETROIT MI 48201